CH585747A5 - - Google Patents

Info

Publication number
CH585747A5
CH585747A5 CH718876A CH718876A CH585747A5 CH 585747 A5 CH585747 A5 CH 585747A5 CH 718876 A CH718876 A CH 718876A CH 718876 A CH718876 A CH 718876A CH 585747 A5 CH585747 A5 CH 585747A5
Authority
CH
Switzerland
Application number
CH718876A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH835473A priority Critical patent/CH585745A5/xx
Priority to CH718776A priority patent/CH585746A5/xx
Priority to CH718876A priority patent/CH585747A5/xx
Priority to AU69362/74A priority patent/AU486305B2/en
Priority to DE2426040A priority patent/DE2426040C2/de
Priority to CA201,871A priority patent/CA1030545A/en
Priority to BE145116A priority patent/BE815967A/xx
Priority to LU70255A priority patent/LU70255A1/xx
Priority to FR7419507A priority patent/FR2232309B1/fr
Priority to NL7407672A priority patent/NL7407672A/xx
Priority to GB2538174A priority patent/GB1449297A/en
Priority to AT474574A priority patent/AT339318B/de
Priority to JP49064159A priority patent/JPS6020392B2/ja
Priority to GB1321476A priority patent/GB1449299A/en
Priority to GB1321576A priority patent/GB1449300A/en
Priority to US500770A priority patent/US3928383A/en
Priority to US05/613,680 priority patent/US4005105A/en
Priority to GB1321376*[A priority patent/GB1449298A/en
Priority to US05/714,166 priority patent/US4035385A/en
Priority to US05/714,165 priority patent/US4035386A/en
Priority to AT623276A priority patent/AT340439B/de
Priority to AT623376A priority patent/AT340440B/de
Publication of CH585747A5 publication Critical patent/CH585747A5/xx
Priority to CA291,666A priority patent/CA1038874A/en
Priority to CA291,667A priority patent/CA1043342A/en
Priority to CA291,668A priority patent/CA1038875A/en
Priority to JP57057457A priority patent/JPS6029715B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14—[b,f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH718876A 1973-06-08 1973-06-08 CH585747A5 (xx)

Priority Applications (26)

Application Number Priority Date Filing Date Title
CH835473A CH585745A5 (xx) 1973-06-08 1973-06-08
CH718776A CH585746A5 (xx) 1973-06-08 1973-06-08
CH718876A CH585747A5 (xx) 1973-06-08 1973-06-08
AU69362/74A AU486305B2 (en) 1973-06-08 1974-05-24 DIBENZO (b, f) THIE PINES AND DIBENZO (b, f) OXEPINES
DE2426040A DE2426040C2 (de) 1973-06-08 1974-05-30 Dibenzo[b,f]oxepin-oder-thiepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Präparate
CA201,871A CA1030545A (en) 1973-06-08 1974-06-06 Propynylamine-substituted dibenzo (b,f) thiepins and dibenzo (b,f) oxepins
BE145116A BE815967A (fr) 1973-06-08 1974-06-06 Composes tricycliques
LU70255A LU70255A1 (xx) 1973-06-08 1974-06-06
FR7419507A FR2232309B1 (xx) 1973-06-08 1974-06-06
GB1321476A GB1449299A (en) 1973-06-08 1974-06-07 Tricyclic compounds
GB2538174A GB1449297A (en) 1973-06-08 1974-06-07 Tricyclic compounds
AT474574A AT339318B (de) 1973-06-08 1974-06-07 Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen
JP49064159A JPS6020392B2 (ja) 1973-06-08 1974-06-07 ジベンゾチエピン誘導体の製造方法
NL7407672A NL7407672A (xx) 1973-06-08 1974-06-07
GB1321576A GB1449300A (en) 1973-06-08 1974-06-07 Tricyclic compounds
US500770A US3928383A (en) 1973-06-08 1974-08-26 Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins
US05/613,680 US4005105A (en) 1973-06-08 1975-09-15 Substituted 10-ethynyldibenzo[b,f]thiepins and dibenz[b,f]oxepins
GB1321376*[A GB1449298A (en) 1973-06-08 1976-06-07 Tricyclic compounds
US05/714,166 US4035385A (en) 1973-06-08 1976-08-13 Substituted dibenzo [b,f]thiepins and dibenz[b,f]oxepins
US05/714,165 US4035386A (en) 1973-06-08 1976-08-13 Propynylamine-substituted dibenzo[b,f]thiepins and dibenz[b,f]oxepins
AT623276A AT340439B (de) 1973-06-08 1976-08-23 Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen
AT623376A AT340440B (de) 1973-06-08 1976-08-23 Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen
CA291,666A CA1038874A (en) 1973-06-08 1977-11-24 Tricyclic compounds
CA291,667A CA1043342A (en) 1973-06-08 1977-11-24 Tricyclic compounds
CA291,668A CA1038875A (en) 1973-06-08 1977-11-24 Tricyclic compounds
JP57057457A JPS6029715B2 (ja) 1973-06-08 1982-04-08 三環式化合物の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH718876A CH585747A5 (xx) 1973-06-08 1973-06-08
CH718776A CH585746A5 (xx) 1973-06-08 1973-06-08
CH835473A CH585745A5 (xx) 1973-06-08 1973-06-08

Publications (1)

Publication Number Publication Date
CH585747A5 true CH585747A5 (xx) 1977-03-15

Family

ID=27175724

Family Applications (3)

Application Number Title Priority Date Filing Date
CH718776A CH585746A5 (xx) 1973-06-08 1973-06-08
CH718876A CH585747A5 (xx) 1973-06-08 1973-06-08
CH835473A CH585745A5 (xx) 1973-06-08 1973-06-08

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH718776A CH585746A5 (xx) 1973-06-08 1973-06-08

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH835473A CH585745A5 (xx) 1973-06-08 1973-06-08

Country Status (10)

Country Link
JP (2) JPS6020392B2 (xx)
AT (1) AT339318B (xx)
BE (1) BE815967A (xx)
CA (1) CA1030545A (xx)
CH (3) CH585746A5 (xx)
DE (1) DE2426040C2 (xx)
FR (1) FR2232309B1 (xx)
GB (4) GB1449297A (xx)
LU (1) LU70255A1 (xx)
NL (1) NL7407672A (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR008371A1 (es) * 1996-05-30 2000-01-19 Novartis Ag Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ

Also Published As

Publication number Publication date
DE2426040C2 (de) 1983-01-27
GB1449299A (en) 1976-09-15
BE815967A (fr) 1974-12-06
GB1449300A (en) 1976-09-15
LU70255A1 (xx) 1976-04-13
AT339318B (de) 1977-10-10
CH585745A5 (xx) 1977-03-15
JPS5035182A (xx) 1975-04-03
AU6936274A (en) 1975-11-27
CH585746A5 (xx) 1977-03-15
ATA474574A (de) 1977-02-15
GB1449297A (en) 1976-09-15
GB1449298A (en) 1976-09-15
FR2232309B1 (xx) 1977-03-11
JPS5823684A (ja) 1983-02-12
JPS6029715B2 (ja) 1985-07-12
DE2426040A1 (de) 1975-01-02
JPS6020392B2 (ja) 1985-05-21
CA1030545A (en) 1978-05-02
FR2232309A1 (xx) 1975-01-03
NL7407672A (xx) 1974-12-10

Similar Documents

Publication Publication Date Title
AU476761B2 (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU471343B2 (xx)
AU476714B2 (xx)
AU476696B2 (xx)
AU466283B2 (xx)
AU472848B2 (xx)
AU477823B2 (xx)
AU471461B2 (xx)
AU477824B2 (xx)
DK137496C (xx)
AU476873B1 (xx)
CH585747A5 (xx)
BE810381A (xx)
AU479539A (xx)
AU479522A (xx)
AU479521A (xx)
AU479504A (xx)
AU479496A (xx)
AU479458A (xx)
AU479453A (xx)

Legal Events

Date Code Title Description
PL Patent ceased